{"id":380417,"date":"2020-11-12T16:35:39","date_gmt":"2020-11-12T21:35:39","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=380417"},"modified":"2020-11-12T16:35:39","modified_gmt":"2020-11-12T21:35:39","slug":"t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","title":{"rendered":"T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">LEXINGTON, Mass., Nov.  12, 2020  (GLOBE NEWSWIRE) &#8212; T2 Biosystems, Inc.\u00a0(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum.<\/p>\n<p>Management is scheduled to present Thursday, November 19, 2020 at 2:30pm ET. Interested parties may access a live and recorded webcast of the presentation on the \u201cInvestors\u201d section of the Company\u2019s website at www.t2biosystems.com.<\/p>\n<p>\n        <strong>About\u00a0T2 Biosystems<\/strong><br \/>\n        <br \/>T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems\u2019 products include the T2Dx<sup>\u00ae<\/sup> Instrument, T2Candida<sup>\u00ae<\/sup> Panel, the T2Bacteria<sup>\u00ae<\/sup> Panel, the T2Resistance<sup>\u00ae<\/sup> Panel, and the T2SARS-CoV-2\u2122 Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR<sup>\u00ae<\/sup>) technology. T2 Biosystems has an active pipeline of future products, including the T2Cauris\u2122 Panel, and T2Lyme\u2122 Panel, as well as additional products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers, and biothreat pathogens.<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Gina Kent,\u00a0Vault Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tGjQJe1_SEpmHqbnOE13fZjHFsfFVRORowBp5NmhRSFyXkzhq9K2TmCuJGBYkPkkTfsVXA-pZuPPNlGQxP7QaQX3rU_zmGpmIwSOrcf6Y40LipJGnHm4kic3-oyyU3AQ\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">gkent@vaultcommunications.com<\/a><br \/>610-455-2763<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Philip Trip Taylor, Gilmartin Group<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=t1bFhgeVhaTYFQ_AeO_E1y1kzTqfEf_stFRyAheuhjxq11mXFB35FSvFo_9FW-SNrmKzz_sQSsiYBm30LY9wryNueaERO1IDdDF9Q-VrH9k=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">philip@gilmartinIR.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZFaf0zjZ-f2fi6wZDkT6qiKSmrxyaphGcfVMhoGjvsyHzQA0sdm680SIloaxKd4IGaEeEzXp1KukJLqnyQwwf0pq89DvO9EfC1S21dU1KBjhEKKwNcKDBi5p1nZ8NXDTIldIodhqPcgqD3pOc2T1K15wdL4-JdCvmaE1X89rmC_PODtLBOQusE5Phq76pRqa\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/><\/a>415-937-5406<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTM1NyMzODI1MjMwIzIwMDU4NDQ=\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; T2 Biosystems, Inc.\u00a0(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum. Management is scheduled to present Thursday, November 19, 2020 at 2:30pm ET. Interested parties may access a live and recorded webcast of the presentation on the \u201cInvestors\u201d section of the Company\u2019s website at www.t2biosystems.com. About\u00a0T2 Biosystems T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems\u2019 products include the T2Dx\u00ae Instrument, T2Candida\u00ae Panel, the T2Bacteria\u00ae Panel, the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-380417","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; T2 Biosystems, Inc.\u00a0(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum. Management is scheduled to present Thursday, November 19, 2020 at 2:30pm ET. Interested parties may access a live and recorded webcast of the presentation on the \u201cInvestors\u201d section of the Company\u2019s website at www.t2biosystems.com. About\u00a0T2 Biosystems T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems\u2019 products include the T2Dx\u00ae Instrument, T2Candida\u00ae Panel, the T2Bacteria\u00ae Panel, the &hellip; Continue reading &quot;T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T21:35:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTM1NyMzODI1MjMwIzIwMDU4NDQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum\",\"datePublished\":\"2020-11-12T21:35:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\"},\"wordCount\":221,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTM1NyMzODI1MjMwIzIwMDU4NDQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\",\"name\":\"T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTM1NyMzODI1MjMwIzIwMDU4NDQ=\",\"datePublished\":\"2020-11-12T21:35:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTM1NyMzODI1MjMwIzIwMDU4NDQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTM1NyMzODI1MjMwIzIwMDU4NDQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","og_locale":"en_US","og_type":"article","og_title":"T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk","og_description":"LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; T2 Biosystems, Inc.\u00a0(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum. Management is scheduled to present Thursday, November 19, 2020 at 2:30pm ET. Interested parties may access a live and recorded webcast of the presentation on the \u201cInvestors\u201d section of the Company\u2019s website at www.t2biosystems.com. About\u00a0T2 Biosystems T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems\u2019 products include the T2Dx\u00ae Instrument, T2Candida\u00ae Panel, the T2Bacteria\u00ae Panel, the &hellip; Continue reading \"T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T21:35:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTM1NyMzODI1MjMwIzIwMDU4NDQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum","datePublished":"2020-11-12T21:35:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/"},"wordCount":221,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTM1NyMzODI1MjMwIzIwMDU4NDQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/","name":"T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTM1NyMzODI1MjMwIzIwMDU4NDQ=","datePublished":"2020-11-12T21:35:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTM1NyMzODI1MjMwIzIwMDU4NDQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTM1NyMzODI1MjMwIzIwMDU4NDQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/t2-biosystems-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech &amp; Diagnostics Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=380417"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380417\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=380417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=380417"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=380417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}